Literature DB >> 27738063

Brugada syndrome in the young: an assessment of risk factors predicting future events.

Maria Cecilia Gonzalez Corcia1,2, Juan Sieira3, Andrea Sarkozy2, Carlo de Asmundis3, Gian-Battista Chierchia3, Jaime Hernandez Ojeda3, Gudrun Pappaert3, Pedro Brugada3.   

Abstract

AIMS: To investigate the clinical characteristics, prognoses, and presence of risk factors in young patients with Brugada syndrome (BS). METHODS AND
RESULTS: A consecutive cohort of 128 young BS patients (≤25 years old at diagnosis) was analysed. Eighty-eight patients (69%) were asymptomatic, whereas 40 (31%) presented with clinical manifestations of BS. Markers of prognosis and risk were identified upon comparison of these two groups. A history of malignant syncope was strong predictors of ventricular arrhythmic events. Family history of sudden cardiac death (SCD) and mutations in the SCN5A gene did not associate with increased risk. Symptomatic patients presented with significantly abnormal baseline electrical characteristics when compared with the asymptomatic cohort, including spontaneous type I electrocardiograph (ECG) patterns, sinus node dysfunction (SND), first-degree atrioventricular (AV) block, and intra-ventricular conduction delay. The symptomatic group more frequently exhibited atrial arrhythmias. Electrophysiological studies resulted positive more frequently in symptomatic patients, but no risk association for future events could be determined. During the follow-up period (mean: 65 months), 10 arrhythmic events occurred in nine symptomatic patients (event rate: 4.5% per year). No events occurred in the asymptomatic group. Variables significantly associated with arrhythmic events during follow-up were presence of symptoms at diagnosis and spontaneous type I ECG. The presence of atrial arrhythmias and conduction abnormalities was also associated with the risk of arrhythmic events during follow-up.
CONCLUSION: Symptomatic BS in the young age is a rare but malignant condition that can manifest with a spectrum of electrical abnormalities (i.e. SND, atrial tachycardias, AV block, and infra-nodal conduction delay) and result in the extreme cases in lethal arrhythmic events and SCD. Published on behalf of the European Society of Cardiology. All rights reserved.
© The Author 2016. For permissions, please email: journals.permissions@oup.com.

Entities:  

Keywords:  Brugada syndrome; Clinical characterization; Risk stratification

Mesh:

Year:  2017        PMID: 27738063     DOI: 10.1093/europace/euw206

Source DB:  PubMed          Journal:  Europace        ISSN: 1099-5129            Impact factor:   5.214


  13 in total

1.  Family Screening for Brugada Syndrome in Asymptomatic Young Patients. Is it Better not to Know?

Authors:  M Cecilia Gonzalez Corcia; Pedro Brugada
Journal:  Pediatr Cardiol       Date:  2017-05-26       Impact factor: 1.655

2.  Clinical Profile and Long-Term Follow-Up of Children with Brugada Syndrome.

Authors:  Ibrahim El-Battrawy; Gretje Roterberg; Kim Schlentrich; Volker Liebe; Siegfried Lang; Boris Rudic; Erol Tülümen; Xiaobo Zhou; Martin Borggrefe; Ibrahim Akin
Journal:  Pediatr Cardiol       Date:  2019-11-20       Impact factor: 1.655

Review 3.  Epidemiology of inherited arrhythmias.

Authors:  Joost A Offerhaus; Connie R Bezzina; Arthur A M Wilde
Journal:  Nat Rev Cardiol       Date:  2019-10-03       Impact factor: 32.419

4.  Clinical outcome of patients with the Brugada type 1 electrocardiogram without prophylactic implantable cardioverter defibrillator in primary prevention: a cumulative analysis of seven large prospective studies.

Authors:  Pietro Delise; Vincent Probst; Giuseppe Allocca; Nadir Sitta; Luigi Sciarra; Josep Brugada; Shiro Kamakura; Masahiko Takagi; Carla Giustetto; Leonardo Calo
Journal:  Europace       Date:  2018-06-01       Impact factor: 5.214

Review 5.  Assessing Candidacy for Primary Preventative Implantable Cardioverter-defibrillators in Pediatric Patients with Ion Channelopathies: Weighing the Risks and Benefits.

Authors:  Madeline L Townsend; Peter F Aziz
Journal:  J Innov Card Rhythm Manag       Date:  2018-09-15

6.  Concomitant Brugada syndrome substrate ablation and epicardial abdominal cardioverter-defibrillator implantation in a child.

Authors:  Carlo de Asmundis; Gian Battista Chierchia; Giannis G Baltogiannis; Francesca Salghetti; Juan Sieira; Theofilos M Kolettis; Kassiani Tasi; Antonios Vlahos; Jens Czapla; Pedro Brugada; Mark La Meir
Journal:  HeartRhythm Case Rep       Date:  2018-03-17

7.  Association between PR Interval, First-degree atrioventricular block and major arrhythmic events in patients with Brugada syndrome - Systematic review and meta-analysis.

Authors:  Raymond Pranata; Emir Yonas; Veresa Chintya; Hadrian Deka; Sunu Budhi Raharjo
Journal:  J Arrhythm       Date:  2019-05-14

8.  Ventricular Tachyarrhythmia Risk in Paediatric/Young vs. Adult Brugada Syndrome Patients: A Territory-Wide Study.

Authors:  Sharen Lee; Wing Tak Wong; Ian Chi Kei Wong; Chloe Mak; Ngai Shing Mok; Tong Liu; Gary Tse
Journal:  Front Cardiovasc Med       Date:  2021-06-11

Review 9.  Heart rate variability as predictive factor for sudden cardiac death.

Authors:  Francesco Sessa; Valenzano Anna; Giovanni Messina; Giuseppe Cibelli; Vincenzo Monda; Gabriella Marsala; Maria Ruberto; Antonio Biondi; Orazio Cascio; Giuseppe Bertozzi; Daniela Pisanelli; Francesca Maglietta; Antonietta Messina; Maria P Mollica; Monica Salerno
Journal:  Aging (Albany NY)       Date:  2018-02-23       Impact factor: 5.682

Review 10.  Clinical Genetics of Inherited Arrhythmogenic Disease in the Pediatric Population.

Authors:  Estefanía Martínez-Barrios; Sergi Cesar; José Cruzalegui; Clara Hernandez; Elena Arbelo; Victoria Fiol; Josep Brugada; Ramon Brugada; Oscar Campuzano; Georgia Sarquella-Brugada
Journal:  Biomedicines       Date:  2022-01-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.